ARCHIVES

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

This article is from The Cancer Letter archive.

Vol. 02 No. 36 | September 3, 1976

Download PDF Visit The Full Archive

Related Articles

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

July 20, 2012

ODAC Recommends Taxol For Metastatic Breast Cancer

January 7, 1994

RF Numbers To Drop Noticeably Soon, Upton Tells AACR

April 14, 1978

Comprehensive Centers Balk At “Requiring” All Control Programs To Be Funneled Through Them

December 5, 1975

DCE Advisors Approve New Epidemiology RFPs Table Proposed RFA

April 16, 1993

Center Leaders Ok Consortium Center Guidelines, Go Along With Most Core Grant Changes Backed By NCI

April 19, 1985